Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
13,330
-480 (-3.48%)
At close: Jun 19, 2026
Sam-A Pharm. Market Cap
Sam-A Pharm. has a market cap or net worth of 81.36 billion as of June 18, 2026. Its market cap has decreased by -21.82% in one year.
Market Cap
81.36B
Enterprise Value
-15.42B
Revenue
70.93B
Ranking
n/a
PE Ratio
9.15
Stock Price
13,330.00
Market Cap Chart
Since November 29, 2000, Sam-A Pharm.'s market cap has increased from 32.75B to 81.36B, an increase of 148.43%. That is a compound annual growth rate of 3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 81.36B | -15.15% |
| Dec 30, 2025 | 95.88B | -5.98% |
| Dec 30, 2024 | 101.99B | 1.89% |
| Dec 28, 2023 | 100.09B | -1.50% |
| Dec 29, 2022 | 101.62B | -13.95% |
| Dec 30, 2021 | 118.10B | 16.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 91.63B |
| KOREA PHARMA | 91.40B |
| Samik Pharmaceutical Company LTD. | 84.16B |
| Pharos iBio | 81.04B |
| Daehan Nupharm | 79.58B |
| Organoidsciences | 71.72B |
| GL Pharm Tech | 69.72B |
| Sinsin Pharmaceutical | 68.42B |